Infliximab a monoclonal antibody is marketed as Remicade and is used to treat autoimmune diseases. It is used to treat conditions like ulcerative colitis, Crohn's disease, psoriasis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Behçet's disease. It binds to TNF-? thereby preventing autoimmune reaction.
MARKET DYNAMICS
The remicade drug market is driving due to the increasing research on treating autoimmune diseases and growing cases of many autoimmune diseases. Moreover, growing awareness for autoimmune diseases in developed as well as developing countries is likely to create growth opportunities in the market.
MARKET SCOPE
The "Remicade drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Remicade drug market with detailed market segmentation by product type and application. The remicade drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Remicade drug market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The remicade drug market is segmented on the basis of product type, and application. Based on product type the market is segmented as branded drugs and generic drugs. The application segment is divided into crohn's disease, pediatric crohn's disease, ulcerative colitis, pediatric ulcerative colitis, and other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the remicade drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The remicade drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting remicade drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the remicade drug market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the remicade drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The remicade drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting remicade drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the remicade drug market in these regions.
MARKET PLAYERS
The report covers key developments in the remicade drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from remicade drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for remicade drug in the global market. Below mentioned is the list of few companies engaged in the remicade drug market.
The report also includes the profiles of key players in remicade drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck And Co
- Celltrion Inc.
- NAPP Pharmaceuticals
- Janssen Biotech Inc
- PFIZER Inc
- Alvogen
- Nippon Kayaku
- Amgen Inc.
- Ranbaxy Laboratories
- Samsung Bioepis
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Remicade Drug Market - By Product Type
1.3.2 Remicade Drug Market - By Application
1.3.3 Remicade Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. REMICADE DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. REMICADE DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. REMICADE DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. REMICADE DRUG - GLOBAL MARKET OVERVIEW
6.2. REMICADE DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. REMICADE DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRANDED DRUGS
7.3.1. Overview
7.3.2. Branded Drugs Market Forecast and Analysis
7.4. GENERIC DRUGS
7.4.1. Overview
7.4.2. Generic Drugs Market Forecast and Analysis
8. REMICADE DRUG MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CROHN'S DISEASE
8.3.1. Overview
8.3.2. Crohn's Disease Market Forecast and Analysis
8.4. PEDIATRIC CROHN'S DISEASE
8.4.1. Overview
8.4.2. Pediatric Crohn's Disease Market Forecast and Analysis
8.5. ULCERATIVE COLITIS
8.5.1. Overview
8.5.2. Ulcerative Colitis Market Forecast and Analysis
8.6. PEDIATRIC ULCERATIVE COLITIS
8.6.1. Overview
8.6.2. Pediatric Ulcerative Colitis Market Forecast and Analysis
8.7. OTHER
8.7.1. Overview
8.7.2. Other Market Forecast and Analysis
9. REMICADE DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Remicade Drug Market Overview
9.1.2 North America Remicade Drug Market Forecasts and Analysis
9.1.3 North America Remicade Drug Market Forecasts and Analysis - By Product Type
9.1.4 North America Remicade Drug Market Forecasts and Analysis - By Application
9.1.5 North America Remicade Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Remicade Drug Market
9.1.5.1.1 United States Remicade Drug Market by Product Type
9.1.5.1.2 United States Remicade Drug Market by Application
9.1.5.2 Canada Remicade Drug Market
9.1.5.2.1 Canada Remicade Drug Market by Product Type
9.1.5.2.2 Canada Remicade Drug Market by Application
9.1.5.3 Mexico Remicade Drug Market
9.1.5.3.1 Mexico Remicade Drug Market by Product Type
9.1.5.3.2 Mexico Remicade Drug Market by Application
9.2. EUROPE
9.2.1 Europe Remicade Drug Market Overview
9.2.2 Europe Remicade Drug Market Forecasts and Analysis
9.2.3 Europe Remicade Drug Market Forecasts and Analysis - By Product Type
9.2.4 Europe Remicade Drug Market Forecasts and Analysis - By Application
9.2.5 Europe Remicade Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Remicade Drug Market
9.2.5.1.1 Germany Remicade Drug Market by Product Type
9.2.5.1.2 Germany Remicade Drug Market by Application
9.2.5.2 France Remicade Drug Market
9.2.5.2.1 France Remicade Drug Market by Product Type
9.2.5.2.2 France Remicade Drug Market by Application
9.2.5.3 Italy Remicade Drug Market
9.2.5.3.1 Italy Remicade Drug Market by Product Type
9.2.5.3.2 Italy Remicade Drug Market by Application
9.2.5.4 Spain Remicade Drug Market
9.2.5.4.1 Spain Remicade Drug Market by Product Type
9.2.5.4.2 Spain Remicade Drug Market by Application
9.2.5.5 United Kingdom Remicade Drug Market
9.2.5.5.1 United Kingdom Remicade Drug Market by Product Type
9.2.5.5.2 United Kingdom Remicade Drug Market by Application
9.2.5.6 Rest of Europe Remicade Drug Market
9.2.5.6.1 Rest of Europe Remicade Drug Market by Product Type
9.2.5.6.2 Rest of Europe Remicade Drug Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Remicade Drug Market Overview
9.3.2 Asia-Pacific Remicade Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Remicade Drug Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Remicade Drug Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Remicade Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Remicade Drug Market
9.3.5.1.1 Australia Remicade Drug Market by Product Type
9.3.5.1.2 Australia Remicade Drug Market by Application
9.3.5.2 China Remicade Drug Market
9.3.5.2.1 China Remicade Drug Market by Product Type
9.3.5.2.2 China Remicade Drug Market by Application
9.3.5.3 India Remicade Drug Market
9.3.5.3.1 India Remicade Drug Market by Product Type
9.3.5.3.2 India Remicade Drug Market by Application
9.3.5.4 Japan Remicade Drug Market
9.3.5.4.1 Japan Remicade Drug Market by Product Type
9.3.5.4.2 Japan Remicade Drug Market by Application
9.3.5.5 South Korea Remicade Drug Market
9.3.5.5.1 South Korea Remicade Drug Market by Product Type
9.3.5.5.2 South Korea Remicade Drug Market by Application
9.3.5.6 Rest of Asia-Pacific Remicade Drug Market
9.3.5.6.1 Rest of Asia-Pacific Remicade Drug Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Remicade Drug Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Remicade Drug Market Overview
9.4.2 Middle East and Africa Remicade Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Remicade Drug Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Remicade Drug Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Remicade Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Remicade Drug Market
9.4.5.1.1 South Africa Remicade Drug Market by Product Type
9.4.5.1.2 South Africa Remicade Drug Market by Application
9.4.5.2 Saudi Arabia Remicade Drug Market
9.4.5.2.1 Saudi Arabia Remicade Drug Market by Product Type
9.4.5.2.2 Saudi Arabia Remicade Drug Market by Application
9.4.5.3 U.A.E Remicade Drug Market
9.4.5.3.1 U.A.E Remicade Drug Market by Product Type
9.4.5.3.2 U.A.E Remicade Drug Market by Application
9.4.5.4 Rest of Middle East and Africa Remicade Drug Market
9.4.5.4.1 Rest of Middle East and Africa Remicade Drug Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Remicade Drug Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Remicade Drug Market Overview
9.5.2 South and Central America Remicade Drug Market Forecasts and Analysis
9.5.3 South and Central America Remicade Drug Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Remicade Drug Market Forecasts and Analysis - By Application
9.5.5 South and Central America Remicade Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Remicade Drug Market
9.5.5.1.1 Brazil Remicade Drug Market by Product Type
9.5.5.1.2 Brazil Remicade Drug Market by Application
9.5.5.2 Argentina Remicade Drug Market
9.5.5.2.1 Argentina Remicade Drug Market by Product Type
9.5.5.2.2 Argentina Remicade Drug Market by Application
9.5.5.3 Rest of South and Central America Remicade Drug Market
9.5.5.3.1 Rest of South and Central America Remicade Drug Market by Product Type
9.5.5.3.2 Rest of South and Central America Remicade Drug Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL REMICADE DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. REMICADE DRUG MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELLTRION INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NAPP PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JANSSEN BIOTECH INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ALVOGEN
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NIPPON KAYAKU
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AMGEN INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RANBAXY LABORATORIES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SAMSUNG BIOEPIS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Merck And Co
2. Celltrion Inc.
3. NAPP Pharmaceuticals
4. Janssen Biotech Inc
5. PFIZER Inc
6. Alvogen
7. Nippon Kayaku
8. Amgen Inc.
9. Ranbaxy Laboratories
10. Samsung Bioepis
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Remicade Drug Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)